𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Regulation of p42 Mitogen-Activated-Protein Kinase Activity by Protein Phosphatase 2A Under Conditions of Growth Inhibition by Epidermal Growth Factor in A431 Cells

✍ Scribed by Naima Chajry; Pierre-Marie Martin; Claude Cochet; Yolande Berthois


Book ID
115131740
Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
980 KB
Volume
235
Category
Article
ISSN
1432-1327

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Involvement of p38 mitogen-activated pro
✍ Ja-Young Kim; Jung-A Choi; Tae-Hwan Kim; Young-Do Yoo; Jong-Il Kim; Yong J. Lee; πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 257 KB πŸ‘ 2 views

## Abstract It is well‐known that p38 mitogen‐activated protein kinase (p38MAPK) participates in cellular responses to mitogenic stimuli, environmental and genotoxic stresses, and apoptotic agents. Although there are several reports on p38MAPK in relation to cell growth and apoptosis, the exact mec

Involvement of hepatocyte epidermal grow
✍ Ziqiu Wang; Meifang Wang; Brian I. Carr πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 173 KB πŸ‘ 3 views

Compound 5 (Cpd 5), a synthetic K vitamin analogue, or 2-(2-mercaptoethanol)-3-methyl-1,4-naphthoquinone, is a potent inhibitor of epidermal growth factor (EGF)-induced rat hepatocyte DNA synthesis and induces EGF receptor (EGFR) tyrosine phosphorylation. To understand the cellular responses to Cpd